Central nervous system sites of the sleep promoting effects of eszopiclone in rats - PubMed (original) (raw)
Central nervous system sites of the sleep promoting effects of eszopiclone in rats
S Kumar et al. Neuroscience. 2011.
Abstract
We examined the effects of eszopiclone (ESZ), a GABA-A receptor agonist in current clinical use as a hypnotic medication, on the activity of subcortical wake- and sleep-active neuronal populations in the rat brain. Sleep-wake states were quantified after i.p. injections of ESZ (3 and 10 mg/kg) or vehicle administered early in the dark phase, when rats are spontaneously awake. Rats were euthanized 2 h post-injection and brain tissue was processed for c-Fos protein immunoreactivity (IR) and for neurotransmitter markers. ESZ at 3 and 10 mg/kg increased time spent in non-rapid-eye-movement (nonREM) sleep, but had no significant effect on Fos-IR in GABAergic neurons in the preoptic hypothalamus that normally express c-Fos during sleep. Among wake-active cell types examined, Fos-IR in hypocretin (HCRT) neurons in the perifornical lateral hypothalamus (LH) was reduced following 3 and 10 mg/kg ESZ. At 10 mg/kg, ESZ suppressed Fos-IR in cholinergic and noncholinergic neurons in the basal forebrain and in serotonergic and nonserotonegic neurons in the dorsal raphe. Having determined that HCRT neurons were responsive to the low dose of systemic ESZ, we unilaterally perfused ESZ directly into the LH of awake rats, using reverse microdialysis. Perfusion of ESZ at 50 μM into the LH for 2 h suppressed waking-related Fos-IR in HCRT neurons, but not in nonHCRT neurons ipsilateral to the dialysis probe. Bilateral LH perfusion of ESZ at 50 μM for 2 h early in the dark phase significantly increased sleep. These findings demonstrate that sleep induction by ESZ does not require activation of GABAergic sleep-regulatory neurons in the preoptic hypothalamus, and identify suppression of HCRT neurons in the LH and suppression of basal forebrain and dorsal raphe neurons as potential mechanisms underlying the sleep-promoting effects of ESZ.
Published by Elsevier Ltd.
Similar articles
- Potentiating effect of eszopiclone on GABA(A) receptor-mediated responses in pedunculopontine neurons.
Ye M, Garcia-Rill E. Ye M, et al. Sleep. 2009 Jul;32(7):879-87. doi: 10.1093/sleep/32.7.879. Sleep. 2009. PMID: 19639750 Free PMC article. - Effects of serotonin on perifornical-lateral hypothalamic area neurons in rat.
Kumar S, Szymusiak R, Bashir T, Rai S, McGinty D, Alam MN. Kumar S, et al. Eur J Neurosci. 2007 Jan;25(1):201-12. doi: 10.1111/j.1460-9568.2006.05268.x. Eur J Neurosci. 2007. PMID: 17241281 - Hippocampal adult neurogenesis is enhanced by chronic eszopiclone treatment in rats.
Methippara M, Bashir T, Suntsova N, Szymusiak R, McGinty D. Methippara M, et al. J Sleep Res. 2010 Sep;19(3):384-93. doi: 10.1111/j.1365-2869.2010.00833.x. Epub 2010 Apr 7. J Sleep Res. 2010. PMID: 20408925 Free PMC article. - [Neurochemical mechanisms of sleep regulation].
[No authors listed] [No authors listed] Glas Srp Akad Nauka Med. 2009;(50):97-109. Glas Srp Akad Nauka Med. 2009. PMID: 20666118 Review. Serbian. - Serotonin control of sleep-wake behavior.
Monti JM. Monti JM. Sleep Med Rev. 2011 Aug;15(4):269-81. doi: 10.1016/j.smrv.2010.11.003. Epub 2011 Apr 2. Sleep Med Rev. 2011. PMID: 21459634 Review.
Cited by
- The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA A Receptors Containing γ1, γ2, and γ3 Subunits.
Richter G, Liao VWY, Ahring PK, Chebib M. Richter G, et al. Front Neurosci. 2020 Nov 19;14:599812. doi: 10.3389/fnins.2020.599812. eCollection 2020. Front Neurosci. 2020. PMID: 33328871 Free PMC article. - Cognitive behavioral therapy for insomnia combined with eszopiclone for the treatment of sleep disorder patients transferred out of the intensive care unit: A single-centred retrospective observational study.
Zhang Y, Su J, Wang J, Tang G, Hu W, Mao J, Ren W, Liu Y, Yu Z. Zhang Y, et al. Medicine (Baltimore). 2018 Sep;97(37):e12383. doi: 10.1097/MD.0000000000012383. Medicine (Baltimore). 2018. PMID: 30213004 Free PMC article. - Eszopiclone and dexmedetomidine depress ventilation in obese rats with features of metabolic syndrome.
Filbey WA, Sanford DT, Baghdoyan HA, Koch LG, Britton SL, Lydic R. Filbey WA, et al. Sleep. 2014 May 1;37(5):871-80. doi: 10.5665/sleep.3650. Sleep. 2014. PMID: 24790265 Free PMC article. - Sites of action of sleep and wake drugs: insights from model organisms.
Rihel J, Schier AF. Rihel J, et al. Curr Opin Neurobiol. 2013 Oct;23(5):831-40. doi: 10.1016/j.conb.2013.04.010. Epub 2013 May 23. Curr Opin Neurobiol. 2013. PMID: 23706898 Free PMC article. Review. - Adenosine A(2A) receptors regulate the activity of sleep regulatory GABAergic neurons in the preoptic hypothalamus.
Kumar S, Rai S, Hsieh KC, McGinty D, Alam MN, Szymusiak R. Kumar S, et al. Am J Physiol Regul Integr Comp Physiol. 2013 Jul 1;305(1):R31-41. doi: 10.1152/ajpregu.00402.2012. Epub 2013 May 1. Am J Physiol Regul Integr Comp Physiol. 2013. PMID: 23637137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources